Eagle Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-162,768
Closed -$4.17M 597
2020
Q2
$4.17M Sell
162,768
-246,017
-60% -$6.11M 0.02% 384
2020
Q1
$9.88M Sell
408,785
-60,205
-13% -$1.47M 0.06% 270
2019
Q4
$11.6M Buy
468,990
+191,170
+69% +$4.44M 0.06% 287
2019
Q3
$5.92M Sell
277,820
-16,912
-6% -$463K 0.03% 379
2019
Q2
$9.36M Sell
294,732
-35,019
-11% -$1.1M 0.05% 320
2019
Q1
$10.9M Sell
329,751
-12,970
-4% -$404K 0.06% 296
2018
Q4
$11M Buy
342,721
+13,699
+4% +$517K 0.07% 277
2018
Q3
$14.1M Buy
329,022
+96,451
+41% +$4.56M 0.07% 292
2018
Q2
$10.7M Sell
232,571
-20,004
-8% -$886K 0.06% 319
2018
Q1
$10M Buy
252,575
+26,452
+12% +$980K 0.05% 314
2017
Q4
$7.58M Buy
226,123
+71,744
+46% +$2.55M 0.04% 363
2017
Q3
$5.78M Buy
+154,379
New +$5.8M 0.03% 414
2015
Q2
Sell
-335,851
Closed -$11.9M 663
2015
Q1
$11.9M Buy
+335,851
New +$10.8M 0.07% 301

Other funds holding PAHC

Eagle Asset Management's PAHC Position: Q3 2020 in Review

Eagle Asset Management sold out of Phibro Animal Health (PAHC) in Q3 2020, closing a stake of 162,768 shares — an estimated $4.17M sold.

Eagle Asset Management first reported a position in PAHC in Q1 2015 and held it in 13 quarters. The position peaked at $14.1M in Q3 2018. 136 funds tracked by Wall St. Rank hold PAHC as of Q3 2020.

  • Eagle Asset Management reported no remaining Phibro Animal Health position as of Q3 2020 after selling out during the quarter.
  • Eagle Asset Management sold 162,768 Phibro Animal Health shares in Q3 2020, an estimated $4.17M.
  • Eagle Asset Management first reported a position in Phibro Animal Health in Q1 2015 and held it in 13 quarters.
  • Eagle Asset Management's Phibro Animal Health position peaked at $14.1M in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2020.

Based on Eagle Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.